Zydus Pharmaceuticals (USA) Inc. is the US generic drug division of a much larger company known as Zydus Lifesciences. Zydus Lifesciences is a global, fully integrated pharmaceutical company with a presence in 50 countries and is committed to growing its presence around the world and in the Un...
Zydus Pharmaceuticals (USA) Inc. is the US generic drug division of a much larger, India-based company known as Zydus Cadila Healthcare. Zydus Cadila is a global, fully integrated pharmaceutical company with a presence in 50 countries and is committed to growing its presence around the world a...
Ursodiol suppresses hepatic synthesis and secretion of cholesterol; and also inhibits intestinal absorption of cholesterol. It appears to have little inhibitory effect on synthesis and secretion into bile of endogenous bile acids, and does not appear to affect secretion of phospholipids into bile. With ...
The article focuses on Zydus Pharmaceuticals (USA), Inc., currently ranked the 8th largest unbranded generic corporation in the U.S. market based on dispensed prescriptions. Topics discussed include its recent launches such as potassium chloride extended-release tablets 8 mEq, etomidate injection and...
Zydus Pharmaceuticals (USA) Inc.: This fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom...
Supernus Pharmaceuticals United States Supernus' Trokendi XR deal delays Zydus generic to 2023 Indian drugmaker Zydus Cadila has announced that it has finalized an agreement with the USA 's Supernus Pharmaceuticals to settle all outstanding patent litigation related to Trokendi XR extended-release capsule...
Zydus Pharmaceuticals (USA) Inc. is a globally integrated generic pharmaceutical company with a focus on providing quality, affordable generic drugs to the US market. Our US leadership, which has over 60 years of US generic market experience, understands the customer’s business which allows Zydus...
Zydus Pharmaceuticals (USA) Inc. 73 Route 31 N. Pennington, NJ 08534 P: 609-730-1900 F: 609-730-1998 Additional Locations Zydus Lifesciences Ltd. Zydus Corporate Park Scheme No. 63, Survey No. 536, Khoraj (Gandhinagar) Nr. Vaishnodevi Circle, S.G. Highway ...
To report an adverse event, please call 877-993-8779 Prompt 2, email Medicalaffairs@zydususa.com, or fax +1-609-559-0699. Hours of operation are 9:00AM to 5:00PM EST Monday through Friday. You are also encouraged to report negative side effects of prescription drugs to the FDA. Vis...